A series of novel ketoprofen derivatives 4a-j bearing both amide and carbamate functionalities were prepared using benzotriazole. Selective reduction of ketoprofen produced hydroxy derivative 2, which reacts with one or two moles of 1-benzotriazole carboxylic acid chloride 1 gave benzotriazole derivatives 3a and 3b respectively. Antioxidative screenings revealed that the prepared compounds 3b and 4a-j possess excellent lipid peroxidation inhibition at 0. 
Introduction
Ketoprofen (Ket) is a non-steroidal anti-inflammatory drug (NSAID) with pronounced analgesic and antipyretic properties. Various ketoprofen derivatives have been synthesized in order to minimize side-effects, prolong plasma half-life and increase solubility [1, 2] . Some amides have proved to be useful prodrugs, while the others possess anti-inflammatory activity independent of the parent compound. It has been demonstrated that amidation of NSAIDs improves selectivity towards COX-2 [3] , while modification of the carboxylic group to hydroxamic acid leads to inhibition of both cyclooxygenase and 5-lipoxygenase, these two enzymes are crucial in inflammatory processes [4, 5] . Glycine amides of ketoprofen and severalother well-known NSAIDs are significantly less irritating to gastric mucosa, while their anti-inflammatory activities are comparable to their parent drugs [6] . Numerous studies suggest that NSAIDs are promising anticancer drugs and may be associated with reduced risk of colon, lung, liver and other types of cancers [7] . In this paper, a series of novel amidocarbamate derivatives of ketoprofen 4a-j was prepared, characterized and screened for their antioxidative, cytostatic and antiviral activities.
Methods
Benzotriazolides 3a, 3b were prepared from the reduced ketoprofen derivative 2 and 1-benzotriazole carboxylic acid chloride 1, presented in Scheme 1 [8, 9] . If the reaction was performed with 1 equivalent of chloride 1 then product 3a with free hydroxy group was obtained in 75% yield. When the reaction was carried out with 2 equivalents of chloride 1, the main product was benzotriazolide 3b, in which both carboxylic and hydroxy groups were acylated. Minor amount of product 3a was detected, even if the reaction was performed with the excess of chloride 1. The reaction was carried out at room temperature in order to avoid benzotriazolide 3a polycondensation. Compounds 4a-j was prepared by the reaction of benzotriazolide 3b with 2 equivalents of an appropriate amine, in the presence of 5 equivalents of triethylamine ( Table  1 ). All reactions were performed in toluene, at room temperature, for 0.5-48 h. Triethylamine formed a water soluble salt with benzotriazole, a by-product of the reac- C NMR spectra and confirmed by the elemental analysis. The chemical shifts were consistent with the proposed structures of the novel compounds presented in Table 2 .
Chemistry
Melting points were determined on a Stuart Melting Point Apparatus SMP3 and were uncorrected. IR spectra were recorded on a FTIR Perkin Elmer Paragon 500 spectrometer.
1 H and 13 C NMR spectra were recorded on a Varian Gemini 300 spectrometer, operating at 300 and 75.5 MHz for the 1 H and 13 C nuclei, respectively. Samples were measured in DMSO-d 6 solutions at 20ºC in 5-mm NMR tubes. Chemical shifts () were referred to TMS. Coupling constants (J) are given in Hz. Elemental analysis was determined on CHN-LECO-932 and the elemental composition of the compounds agreed within 0.4%. For thin-layer chromatography, precoated Merck silica gel 60 F254 and solvent system cyclohexane/ethyl acetate/methanol (3:1:0.5) were used. Spots were visualized by short-wave UV light and iodine vapor. Column chromatography was performed on Merck silica gel 0.063-0.200 mm with cyclohexane/ethyl acetate (1:2, 2:1→1:1, 1:1) as eluents. Benzotriazole, triphosgene, triethylamine, cyclopentylamine, cyclohexylamine, cyclohexanemethylamine, benzylamine, 2-phenyle-thylamine, pyrrolidine, piperidine, O-methylhydroxylamine hydrochloride, O-benzylhydroxylamine hydrochloride, ethylenediamine, 10% Pd/C, DPPH, AAPH, nordihydroguaiaretic acid (NDGA), sodium linoleate, soybean lipoxygenase, caffeic acid and trolox were purchased from Sigma-Aldrich. O-ethylhydroxylamine hydrochloride was obtained from E. Merck, India, CDH, s.d. Fine Chem. and Qualigens, India. Ketoprofen was obtained as a gift sample from Ranbaxy Laboratories Ltd., India. All solvents were of analytical grade and were dried prior to use.
1-Benzotriazole Carboxylic Acid Chloride
(Btcocl, 1) BtCOCl was prepared from benzotriazole and triphosgene [8] . 
2-(3-(Hydroxy(phenyl)methyl)phenyl)propanoic acid (2)
2-(3-(Hydroxy(phenyl)methyl)phenyl)propanoic acid (2) was prepared by the catalytic hydrogenation of ketoprofen using H 2 /Pd/C(en)/tetrahydrofurane [14] .
Benzotriazolides 3a,b. General Procedure
To a solution of 2 (2.561 g, 10 mmol 2 and triethylamine (10 or 28 mmol) in dry toluene (20 or 50 mL), a solution of chloride 1 (10 or 28 mmol) in dry toluene (20 or 50 mL) was added dropwise (15 min). The reaction mixture was stirred at room temperature for 60 min. and extracted 4 times with water. The organic layer was dried over anhydrous sodium sulphate, filtrated and evaporated. Thus obtained crude products were purified by trituration with ether.
2-(3-(Hydroxy(phenyl)methyl)phenyl)propanoic
Acid Benzotriazolide (3a) From the reaction of 2, chloride 1 (1.696 g, 10 mmol), and triethylamine (1.393 mL, 10 mmol) in dry toluene (2×20 mL 
Amidocarbamates 4a-j General Procedure
A solution of benzotriazolide 3b (0.5 mmol), the appropriate amine (1.1 mmol) and triethylamine (0.348 mL, 2.5 mmol) in toluene (5 mL) was stirred at room temperature for 30 min -48 h. The reaction mixture was extracted with brine (5 × 10 mL), hydrochloric acid (w = 1%, 1 × 5 mL) and washed with water till pH 7. After drying (anhydrous sodium sulphate) and evaporation of the solvent, the crude product was obtained.
(3-(1-(Methoxycarbamoil)ethyl)phenyl)(Phenyl) Methyl Methoxycarbamate (4a)
To the product 3b, O-methylhydroxylamine hydrochloride (0.092 g, 0.5 mmol) and triethylamine was added at room temperature and stirred for 10 h. After purification by the column chromatography (eluent cyclohexane/ethyl acetate 1:2) 0.143 g (80%) of 4a was obtained; 
(3-(1-(Cyclohexylcarbamoil)ethyl)phenyl) (phenyl)methyl Cyclohexylcarbamate (4e)
To
(3-(1-(Benzylcarbamoil)ethyl)phenyl)(phenyl)
Methyl Benzylcarbamate (4g) To the product 3b, benzylamine (0.120 mL, 0.5 mmol) and triethylamine was added at room temperature and stirred for 30 min. After trituration with ether 0.127 g (53%) of 4g 3-(1-Oxo-1-(pyrrolidin-1-yl) propan-2-yl) phenyl)(phenyl)methyl Pyrrolidine-1-Carboxylate (4i) To the product 3b, pyrrolidine (0.092 mL, 0.5 mmol) and triethylamine was added at room temperature and stirred for 30 min. After evaporation 0.152 g (75%) of 4i was 
Interaction with DPPH
To a solution of DPPH (0.05 mM) in absolute ethanol an equal volume of 0.1 or 0.05 mM ethanolic solution of the tested compound was added [10] . After 20 and 60 min the absorbance was recorded at 517 nm and compared to the appropriate standard NDGA ( Table 3) . Ethanol was used as a control. Each in vitro experiment was performed at least in triplicate and the standard deviation of absorbance was less than 10% of the mean.
Soybean Lipoxygenase Inhibition
DMSO solution of the tested compound was incubated with sodium linoleate (0.1 mM) and 0.2 mL of soybean lipoxygenase solution (1/9 × 10 4 w/v in saline) at room temperature [10] . The conversion of sodium linoleate to 13-hydroperoxylinoleic acid was recorded at 234 nm and compared to the standard inhibitor caffeic acid.
Inhibition of Linoleic Acid Lipid Peroxidation
Oxidation of linoleic acid to conjugated diene hydro peroxide in an aqueous dispersion is monitored at 234 nm [15] . AAPH was used as a free radical initiator. Tenmicroliters of the 16 mM linoleic acid dispersion was added to the UV cuvette containing 0.93 mL of 0.05 M phosphate buffer, pH 7.4 prethermostated at 37°C. The oxidation reaction was initiated at 37°C under air by the addition of 50 μL of 40 mM AAPH solution. Oxidation was carried out in the presence of compounds (10 μL, final concentration 0.1 mM). In the assay with no antioxidant lipid oxidation was measured in the presence of the same level of DMSO. The rate of oxidation was monitored at 37°C by recording the increase of absorption at 234 nm caused by conjugated diene hydroperoxides. The results were compared to the standard inhibitor trolox.
Antiviral and Cytostatic Activity Assays
Murine leukemia L1210, murine mammary carcinoma FM3A and human T-lymphocyte CEM cells were suspended at 300,000500,000 cells/mL of culture medium, and 100 µL of a cell suspension was added to 100 µL of an appropriate dilution of the test compounds in wells of 96-well microtiter plates. After incubation at 37°C for two (L1210, FM3A) or three (CEM) days, the cell number was determined using a Coulter counter. The IC 50 was defined as the compound concentration required to inhibit cell proliferation by 50%. 
Results and Discussion

Biological Studies
Antioxidant Activity
The interaction of the examined compounds with the stable free radical 1,1-diphenyl-2-picrylhydrazyl (DPPH) was studied. Interaction with DPPH indicates radical scavenging ability in an iron-free system. Interactions were monitored after 20 and 60 min at two concentrations of DPPH (0.05 and 0.1 mM). Ketoprofen, the prototype compound, benzotriazolide 3b as well as all the tested compounds presented very low interaction values. The results are presented in Table 3 .
Soybean Lipoxygenase Inhibition
Compounds were further evaluated for the inhibition of soybean lipoxygenase (LOX) by the UV absorbance based enzyme assay [10] . Lipoxygenases oxidize certain fatty acids at specific positions to hydroperoxides, precursors of leukotrienes, which contain a conjugated triene structure, i.e., soybean lipoxygenase converts linoleic to 13-hydroperoxylinoleic acid. Leukotrienes play an important role as inflammatory and allergic mediators [11] . Inhibitors of LOX have attracted attention initially as potential agents for the treatment of inflammatory and allergic diseases but their therapeutic potential has now been expanded to certain types of cancer and cardiovascular diseases [12] . Most of the LOX inhibitors are antioxidants or free radical scavengers, since lipoxygenation occurs via a carboncentered radical [13] . According to IC 50 values compound 3b is the most active as compared to compounds 4g, 4d and 4f (IC 50 = 2195 μM). From Table 3 it is obvious that aromatic and cycloalkyl derivatives 4g, 4d and 4f are more potent lipoxygenase inhibitors than the other amidocarbamates.
Inhibition of Linoleic Acid Lipid Peroxidation
Azo compounds generating free radicals through spontaneous thermal decomposition are useful for free radical production studies in vitro. The water soluble azo compound 2,2'-azobis(2-amidinopropane) dihydrochloride (AAPH) has been extensively used as a clean and controllable source of thermally produced alkylperoxyl free radicals. In this study AAPH was used as a free radical initiator to follow oxidative changes of linoleic acid to conjugated diene hydroperoxide. The results indicated that all the compounds are excellent inhibitors of lipid peroxidation (LP) (54.599.5%), significantly higher than ketoprofen (69.3%) at 0.1 mM concentration ( Table  3) . This inhibition was found to be concentration dependent.
Regression analysis of the lipid peroxidation inhibition at 100 μM revealed that the overall molar refractivity (OMR) is the main physicochemical parameter influencing the inhibition. The linear OMR model suggests that the compounds with high OMR value will be more active. No correlation for lipophilicity was found.
log LP % = 0.047 (0.018) OMR -1.317 (0.234) n = 11, r = 0.894, r 2 = 0.800, q 2 = 0.680, s = 0.045, F 1,8 = 31.555, α = 0.01
Antiviral and Cytostatic Evaluation
Antiviral evaluation was performed on a series of DNA and RNA viruses: herpes simplex virus type 1 (HSV-1), HSV-2 (G), vaccinia virus, vesicular stomatitis virus, parainfluenza-3, reovirus-1, Sindbis, Coxsackie B4, Punta Toro virus, vesicular stomatitis virus, Coxsackie virus B4, respiratory syncytial virus, influenza A (H1N1; H3N2), influenza B, HIV-1(III B ) and HIV-2(ROD). No selective antiviral effects were noted for any of the tested compounds against any of the viruses evaluated at subtoxic compound concentrations (data not shown). Only 4g showed minor antiviral activity against vesicular stomatitis virus, Coxsackie virus B4 and Punta Toro virus. However, the activity was found at compound concentrations close to their cytostatic activities, pointing to a toxic rather than
